Tumour lysis syndrome
| Headline | |
|---|---|
| Etiology | following typically lymphoproliferative malignancy and chemo/radiotherapy or steroids - typically 12-72h post chemo |
| Epidemiology | |
| Clinical presentation | GI upset, haematuria, fluid overload B: fluid overload? C: arrhythmia, shock D: weakness, tetany E: renal failure |
| Pathogenesis | Cell breakdown, releasing intracellular toxic contents... like Rhabdomyolysis?? - Purine nucleic acids in circulation → ↑ urate - Renal impairment: ↓ volume, tubular necrosis, precipitation of uric acid crystals, ↓ renal perfusion |
| Diagnostic investigations | Bloods: ↑ K, ↑ PO4, Hypocalcaemia, ↑ urate, renal failure, ↑ LDH, metab acidosis |
| Management | Treat each electrolyte derangement as you would normally +/- CRRT Urate: rasburicase, allopurinol |
| prevention | risk assessment for patients undergoing chemotherapy + pre-emptively avoiding nephrotoxics |
associations
- poorly differentiated lymphomas, e.g. Burkitt’s lymphoma and high-grade non-Hodgkin lymphoma
- leukaemias, e.g. acute myeloid leukemia (AML), transformed chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL)
- some fast-growing solid tumours such as hepatocellular carcinoma, hepatoblastoma, testicular cancer, small cell lung cancer, breast cancer and neuroblastoma.
related topics
Rhabdomyolysis I swear they're conceptually p much the same